Ancora Finance Group
85 Chelsea Manor Street, London, SW3 5QP, United Kingdom
Overview
Founded in 2012, the Ancora Finance Group (AFG) is engaged in active private growth company investments, the development of proprietary technology-led investment strategies in the public domain and the provision of corporate finance and investment advice. Its principal focus is the provision of growth capital to innovative European companies in the environmental and healthcare sectors. It also has experience in Fintech and other geographic markets, including the US and APAC. The Group has a presence in London, Munich and Zurich
- Total investments
- 2
- Lead investments
- 2
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Finance
- Financial Exchanges
- Financial Services
Investment portfolio
- Atlas Medical Technologies
Led · Series A · Jan 2023
Led by CEO Timo Krüger, Atlas medical technologies develops a 4D laser navigation robot that enables precise injections and microsurgery in interventional radiology and orthopedics. The company is based in Bochum, Germany. It raised €2.4M in a Series A financing. The proceeds are intended to expand the company’s operations in Europe. Investors in the round include Ancora Finance Group, Grönemeyer Swiss Health, Beat Drop and Grönemeyer Health. Dr. Krüger called the financing a milestone that encourages their way forward in Europe.
- Koa Health
Led · Series A · Feb 2021
Koa Health provides personalized, science-backed digital mental healthcare solutions for employers, healthcare providers and payers. Its flagship product, Koa Foundations, is a mental wellbeing app with a library of evidence-based activities addressing stress, sleep, relaxation, positive thinking and self-confidence. Koa Foundations is available to more than three million people through contracts with dozens of employers, healthcare providers and payers. The company works with partners including Massachusetts General Hospital, the Max Planck UCL Centre for Computational Psychiatry and Aging Research, and the Birmingham and Solihull Mental Health NHS Foundation Trust. Koa has operations in Barcelona, the US and the UK and is led by CEO Oliver Harrison. Following its Series A close the company plans to accelerate product development, expand its US presence and enhance R&D.
Team
No current team members are available.